Amgen to announce data on obesity drug MariTide at healthcare conference
AmgenAmgen(US:AMGN) Reuters·2026-01-12 23:46

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on Monday to unveil results from a mid-stage trial extension designed to show if the medication helps people maintain weight loss. ...